询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
1,3-Bis(2-hydroxyethoxy)benzene | CAS:102-40-9
1,3-Bis(2-hydroxyethoxy)benzene
  • 名称:1,3-双(2-羟乙氧基)苯; 间苯二酚二(2-羟乙基)醚 | 1,3-Bis(2-hydroxyethoxy)benzene
  • CAS号:102-40-9
  • 别名:2,2'-[1,3-Phenylenebis(oxy)]bisethanol; Resorcinol bis(2-hydroxyethyl) ether
  • 分子式:C10H14O4
  • 分子量:198.22
  • EINESC号:203-028-3

产品描述

物理化学性质

没有数据没有数据

安全数据

没有数据没有数据

SDS

来源 SDS样本
没有数据没有数据
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
Synthesis and biological evaluation of new 4-carboxyl quinoline derivatives as cyclooxygenase-2 inhibitors.Afshin Zarghi et al.Bioorganic & medicinal chemistry, 17(14), 5312-5317 (2009-06-30) Synthesis and 5-HT3 receptor affinity of new quinolinecarboxylic acid derivatives.A Orjales et al.Drug design and discovery, 16(4), 271-279 (2000-05-12) The effect of certain cinchoninic acid derivatives on the renal tubular secretion of phenol red.E H DEARBORN Bulletin of the Johns Hopkins Hospital, 87(4), 328-337 (1950-10-01) Effect of neurohypophysectomy on antidiuretic activity of substituted 3-hydroxy cinchoninic acids in the rat.T H MAREN et al.The American journal of physiology, 164(1), 49-60 (1951-01-01) Microbial metabolism of quinoline and related compounds. XI. Degradation of quinoline-4-carboxylic acid by Microbacterium sp. H2, Agrobacterium sp. 1B and Pimelobacter simplex 4B and 5B.M Schmidt et al.Biological chemistry Hoppe-Seyler, 372(11), 1015-1020 (1991-11-01) Some biological properties of new quinoline-4-carboxylic acid and quinoline-4-carboxamide derivatives.J Strigácová et al.Folia microbiologica, 45(4), 305-309 (2001-05-12) Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390).C L Arteaga et al.Cancer research, 49(16), 4648-4653 (1989-08-15) [3-hydroxy-2-phenylcinchonine acid therapy of rheumatic fever].M IVERSEN Ugeskrift for laeger, 113(26), 851-855 (1951-06-28) Trial of a cinchoninic acid derivative in some collagen diseases.J B RENNIE et al.British medical journal, 1(4703), 383-388 (1951-02-24) Diagnostic value of LncRNA-MEG3 as a serum biomarker in patients with hepatitis B complicated with liver fibrosis.M-J Chen et al.European review for medical and pharmacological sciences, 23(10), 4360-4367 (2019-06-08) Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives.W Knecht et al.Biochemical pharmacology, 56(9), 1259-1264 (1998-11-05) Degradation of quinoline-4-carboxylic acid by Microbacterium sp.P Röger et al.FEMS microbiology letters, 57(3), 279-282 (1989-02-01) Hydrogen bonding in quinolinium-4-carboxylate dihydrate.A J Dobson et al.Acta crystallographica. Section C, Crystal structure communications, 55 ( Pt 6), 935-937 (1999-07-17) Quinoline-4-carboxylic acid.A J Dobson et al.Acta crystallographica. Section C, Crystal structure communications, 54 ( Pt 12), 1883-1885 (1999-01-28) The cardiovascular and respiratory effects of 3-hydroxy-2-phenyl cinchoninic acid.H A WALKER et al.The Journal of pharmacology and experimental therapeutics, 102(2), 71-78 (1951-06-01) Certain aspects of the pharmacology of 3-hydroxycinchoninic acid.K C BLANCHARD et al.Bulletin of the Johns Hopkins Hospital, 88(2), 181-187 (1951-02-01) Rapid synthesis of quinoline-4-carboxylic acid derivatives from arylimines and 2-substituted acrylates or acrylamides under indium(III) chloride and microwave activations. Scope and limitations of the reaction.Dorothée Duvelleroy et al.Organic & biomolecular chemistry, 3(20), 3794-3804 (2005-10-08) 7-Methyl-thiocinchoninamide.A G RENFREW Journal of the American Pharmaceutical Association. American Pharmaceutical Association, 40(9), 467-467 (1951-09-01) [A case of Gaucher's disease treated with hydroxyphenylcinchoninic acid].P DANIEL MARTINEZ et al.Boletin medico del Hospital Infantil de Mexico, 8(2), 189-194 (1951-04-01) Effect of 3-hydroxy-2-phenylcinchoninic acid on renal secretion of phenyl red and penicillin.C G ZUBROD et al.Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 74(4), 671-674 (1950-08-01) Synthesis, characterization and crystal structure of novel mononuclear peroxotungsten(VI) complexes. Insulinomimetic activity of W(VI) and Nb(V) peroxo complexes.Adamantia Maniatakou et al.Journal of inorganic biochemistry, 103(5), 859-868 (2009-04-04) Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives.Murugesan Dinakaran et al.Medicinal chemistry (Shariqah (United Arab Emirates)), 4(5), 482-491 (2008-09-11) Hydrogen bonding in quinolinium-4-carboxylate trihydrate.A J Dobson et al.Acta crystallographica. Section C, Crystal structure communications, 55 ( Pt 7), 1192-1195 (1999-08-13) Time-of-flight accurate mass spectrometry identification of quinoline alkaloids in honey.Tamara Rodríguez-Cabo et al.Analytical and bioanalytical chemistry, 407(20), 6159-6170 (2015-06-05) An estimation of the antipyretic activity of cinchoninic acid derivatives.T H MAREN The Journal of pharmacology and experimental therapeutics, 101(3), 313-316 (1951-03-01) [Hypothalamic lesion with diabetes insipidus treated with cinchoninic acid].P WISING Nordisk medicin, 44(46), 1838-1840 (1950-11-17) A simple and convenient copper-catalyzed tandem synthesis of quinoline-2-carboxylates at room temperature.He Huang et al.The Journal of organic chemistry, 74(15), 5476-5480 (2009-07-04) Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarb oxylic acid sodium salt], against experimental tumors.D L Dexter et al.Cancer research, 45(11 Pt 1), 5563-5568 (1985-11-01) [Experience in the use of chemical compounds for the primary identification and differentiation of enteroviruses].T V Amvros'eva et al.Klinicheskaia laboratornaia diagnostika, (2)(2), 49-51 (2003-04-12) Solid-phase synthesis of substituted quinoline and isoquinoline derivatives using heterocyclic N-oxide chemistry. Tetrahedron Letters, 39(27), 4749-4752 (1998)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交